A recent study has revealed that TNM stage III gastric cancer patients with preoperative anemia (defined as Hb levels < 120 g/L in males and < 110 g/L in females) had a 1.77‐fold higher risk of death compared with patients without anemia [19]. This evidence concerns the gene GSTM1 and anemia.